BSAN:NEOBanco Santander S.A. Shs Sponsored Canadian Depository Receipt Hedged Reg S Analysis
Data as of 2026-03-11 - not real-time
CA$16.19
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The CDR trades at CAD 16.19, comfortably below its 20‑day (16.90) and 50‑day (17.04) simple moving averages, yet still above the 200‑day average (14.42), indicating a short‑term pull‑back within a longer‑term uptrend. Momentum is neutral with an RSI of 44 and a bearish MACD histogram (‑0.18) while volume has been dwindling, pushing the stock toward its near‑term support at 15.53 and away from resistance around 18.39. Volatility is elevated at roughly 49% over the past 30 days and beta is modest (≈0.68), suggesting price swings are pronounced but not overly correlated with broader markets. Fundamentally, the bank posts solid operating (43%) and profit margins (26%) and a respectable ROE of 13%, yet revenue is flat (‑0.5%) and the trailing P/E of 38.5 dwarfs the industry average of 17.1, flagging apparent overvaluation on earnings. Discounted cash‑flow analysis, however, yields a fair value of about 24.1, implying the current price is materially below intrinsic worth, while the extreme‑greed sentiment (78 on the Fear & Greed Index) may be inflating short‑term demand.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and decreasing volume signal limited upside
- Price is near the technical support level of 15.53
- High short‑term volatility (≈49%) adds price uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Current price is well below DCF fair value of 24.09
- Strong operating (43%) and profit margins (26%) support earnings stability
- Price remains above the 200‑day SMA, indicating a longer‑term uptrend
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust profitability metrics (ROE 13%, operating margin 43%)
- Undervalued relative to intrinsic DCF estimate despite high P/E
- Diversified banking franchise with low beta reducing systematic risk
Key Metrics & Analysis
Financial Health
Revenue Growth-0.50%
Profit Margin25.87%
P/E Ratio38.5
ROE13.33%
ROA0.79%
P/B Ratio2.4
Op. Cash FlowCA$4.6B
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI44.0
SupportCA$15.53
ResistanceCA$18.39
MA 20CA$16.90
MA 50CA$17.04
MA 200CA$14.42
MACDBearish
VolumeDecreasing
Fear & Greed Index78.16
Valuation
Fair ValueCA$24.09
GradeUndervalued
TypeValue
Risk Assessment
Beta0.68
Volatility49.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.